 - Histologically or cytologically confirmed metastatic solid tumor, including but not limited to pancreatic adenocarcinoma, breast cancer, melanoma, renal cell carcinoma RCC, colorectal adenocarcinoma, non-small cell lung cancer, and others approved by the principal investigator 